Contribution of metabotropic glutamate receptors to the depression of excitatory postsynaptic potentials during hypoxia

NeuroReport

Volumn 8, Issue 17, 1997, Pages 3667-3671

  De Mendonça, Alexandre ^a   Ribeiro, J A ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Adenosine A1 receptor; DPCPX; Hippocampus; Hypoxia; MCPG; Metabotropic glutamate receptor; MPPG

Indexed keywords

METABOTROPIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN OXYGEN CONSUMPTION; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031466555     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199712010-00003     Document Type: Article

References (26)

1. Lipton P and Whittingham TS. J Physiol 287, 427-438 (1979).
2. Cherubini E, Ben-Ari Y and Krnjevic K. J Neurophysiol 62, 882-895 (1989).
3. Hershkowitz N, Katchman AN and Veregge S. J Neurophysiol 69, 432-441 (1993).
4. Fowler JC, Brain Res 490, 378-384 (1989).
5. Gribkoff VK, Bauman LA and VanderMaelen CP. Brain Res 512, 353-357 (1990).
6. Canhāo P, de Mendonça A and Ribeiro JA. Brain Res 661, 265-273 (1994).
7. Zhu PJ and Krnjevic K. Neuropharmacology 36, 169-176 (1997).
8. Conn PJ and Pinn J-P. Annu Rev Pharmacol Toxicol 37, 205-237 (1997).
9. Baskys A and Malenka RC. J Physiol 444, 687-701 (1991).
10. Gereau RW and Conn PJ. J Neurosci 15, 6879-6889 (1995).
11. Manzoni O and Bockaert J. Eur J Neurosci 7, 2518-2523 (1995).
12. Vignes M, Clarke VRJ, Davies CH et al. Neuropharmacology 34, 973-982 (1995).
13. Scanziani M, Salin PA, Vogt KE et al. Nature 385, 630-634 (1997).
14. Thomsen C, Boel E and Suzdak PD Eur J Pharmacol Mol Pharmacol 267, 77-84 (1994).
15. Hayashi Y, Sekiyama N, Nakanishi S et al. J Neurosci 14, 3370-3377 (1994).
16. Cavanni P, Pinnola V, Mugnaini M et al. Eur J Pharmacol 269, 9-15 (1994).
17. Jane DE, Pittaway K, Sunter DC et al. Neuropharmacology 34, 851-856 (1995).
18. de Mendonça A and Ribeiro JA. Br J Pharmacol 121, 1541-1548 (1997).
19. Sebastiäo AM, Stone TW and Ribeiro JA. Br J Pharmacol 101, 453-459 (1990).
20. Lucchi R, Latini S, de Mendonça A et al. Brain Res 732, 261-166 (1996).
21. Vézquez E, Herro I, Miras-Portugal MT et al. Neuroscience 68, 117-124 (1995).
22. Davies CH, Clarke VRJ, Jane DE et al. Br J Pharmacol 116, 1859-1869 (1995).
23. Opitz T and Reymann KG. NeuroReport 2, 455-457 (1991).
24. Opitz T and Reymann KG. Neuropharmacology 32, 103-104 (1993).
25. Watkins J and Collingridge G. Trends Pharmacol Sci 15, 333-342 (1994).
26. Bushell TJ, Jane DE, Tse H-W et al. Br J Pharmacol 117, 1457-1462 (1996).